Assessing the Pharmacological and Pharmacogenomic Data of PD-1/PD-L1 Inhibitors to Enhance Cancer Immunotherapy Outcomes in the Clinical Setting.

Saved in:
Bibliographic Details
Title: Assessing the Pharmacological and Pharmacogenomic Data of PD-1/PD-L1 Inhibitors to Enhance Cancer Immunotherapy Outcomes in the Clinical Setting.
Authors: Zervanos, Damianos-Ioannis1 (AUTHOR), Galatou, Eleftheria2 (AUTHOR), Miliotou, Androulla N.1,2 (AUTHOR), Theodoroula, Nikoleta F.1,2 (AUTHOR), Grigoriadis, Nikolaos1 (AUTHOR), Vizirianakis, Ioannis S.1,2 (AUTHOR)
Source: Future Pharmacology. Sep2025, Vol. 5 Issue 3, p43. 42p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 188351326
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Assessing the Pharmacological and Pharmacogenomic Data of PD-1/PD-L1 Inhibitors to Enhance Cancer Immunotherapy Outcomes in the Clinical Setting.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Zervanos%2C+Damianos-Ioannis%22">Zervanos, Damianos-Ioannis</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Galatou%2C+Eleftheria%22">Galatou, Eleftheria</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Miliotou%2C+Androulla+N%2E%22">Miliotou, Androulla N.</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Theodoroula%2C+Nikoleta+F%2E%22">Theodoroula, Nikoleta F.</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Grigoriadis%2C+Nikolaos%22">Grigoriadis, Nikolaos</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Vizirianakis%2C+Ioannis+S%2E%22">Vizirianakis, Ioannis S.</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Future+Pharmacology%22">Future Pharmacology</searchLink>. Sep2025, Vol. 5 Issue 3, p43. 42p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=188351326
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/futurepharmacol5030043
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 42
        StartPage: 43
    Titles:
      – TitleFull: Assessing the Pharmacological and Pharmacogenomic Data of PD-1/PD-L1 Inhibitors to Enhance Cancer Immunotherapy Outcomes in the Clinical Setting.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zervanos, Damianos-Ioannis
      – PersonEntity:
          Name:
            NameFull: Galatou, Eleftheria
      – PersonEntity:
          Name:
            NameFull: Miliotou, Androulla N.
      – PersonEntity:
          Name:
            NameFull: Theodoroula, Nikoleta F.
      – PersonEntity:
          Name:
            NameFull: Grigoriadis, Nikolaos
      – PersonEntity:
          Name:
            NameFull: Vizirianakis, Ioannis S.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: Sep2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 26739879
          Numbering:
            – Type: volume
              Value: 5
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Future Pharmacology
              Type: main
ResultId 1